Background Endothelial dysfunction is not only an early stage of atherosclerosis, but also involved in the pathogenesis of cerebral small-vessel diseases. Patients with cerebral microbleeds (CMBs) may have arteriolosclerosis as well as systemic atherosclerosis. However, little is known about the associations among CMBs, atherosclerosis of cerebral large arteries, and endothelial function. Our study aimed to investigate the relationships among them. Methods This was a cross-sectional study. Ninety patients hospitalized in Peking University First Hospital with acute ischemic stroke were enrolled consecutively between November 1, 2007 and January 31, 2008. All subjects underwent transcranial Doppler and carotid color duplex ultrasonography to record the intima-media thickness (IMT) of common carotid artery, carotid plaque, and cerebral artery stenosis. Brain magnetic resonance imaging (MRI) routine sequences and gradient recall-echo T 2 *-weighted imaging were performed to count CMBs with clinical data blindness. Endothelial function was evaluated using flow-mediated dilation (FMD) and nitroglycerin-mediated dilation (NMD) of the brachial artery. FMD and NMD were examined by an experienced vascular sonographer using a high-resolution ultrasound. Results Thirty cases (33.3%) had CMBs with counts ranging from 1 to 30. Both FMD ((9.9±4.8)% vs. (15.2±7.4)%, P=0.001) and NMD ((13.7±6.1)% vs. (19.0±7.4)%, P=0.001) were significantly decreased in CMB-positive patients than in CMB-negative patients. No significant relationships were demonstrated between CMBs and intracranial and/or extracranial artery stenosis. The frequencies of CMBs in patients with IMT≥1.0 mm, carotid plaque, and extracranial artery stenosis were 37.5%, 39.4%, and 47.6% respectively, with no significant difference, but much higher than in patients with IMT <1.0 mm (5%, P <0.05). In Logistic regression analysis, impaired FMD (OR=5.783, 95% CI 1.652-6.718, P=0.007) and high pulse pressure (OR=6.228, 95% CI 1.594-3.891, P=0.009) were independently associated with the presence of CMBs, as well as previous ischemic stroke. In contrast, NMD was not correlated with CMBs. Conclusions CMBs may coexist with cerebral atherosclerosis in ischemic stroke. Endothelial dysfunction may play a role in the pathogenesis of CMBs, but may not simply reflect functional alterations of large arteries.
C erebral microbleeds (CMBs) are reported more frequently in lacunar infarction than atherothrombotic or cardioembolic infarctions. 1 As we know, lacunar infarction is usually visible on magnetic resonance imaging (MRI) without clinical symptoms, even in patients with cerebral large-artery diseases. However, the association between CMBs and cerebral large-artery diseases is unclear so far. Both small-vessel diseases and atherosclerosis are systemic and are associated with vascular risk factors. Therefore, cerebral small-vessel diseases such as CMBs may coexist with systemic atherosclerosis. 2 C M B s a r e c o n s i d e r e d a s a m a n i f e s t a t i o n o f arteriolosclerosis in cerebral small vessels and may have a shared pathogenesis with cerebral white matter lesions (WML) and lacunar infarcts. Increasing evidence suggests that endothelial dysfunction is involved in the pathogenesis of cerebral small-vessel diseases. 3, 4 Flow-mediated dilation (FMD) of the brachial artery is a reliable, noninvasive method to evaluate systemic endothelial function. [5] [6] [7] It measures endothelium-dependent vasodilatation of the brachial artery caused by endogenous nitric oxide, which is released by endothelium when stimulated with reactive hyperemia. Otherwise exogenous nitrogen oxide (NO) provider such as nitroglycerin can generate NO by biological transformation in vivo, thus causing vascular smooth muscle relaxation independent of the endothelium. It is reported that low FMD was evident in WML and lacunar infarcts. 8, 9 However, the association between CMBs and FMD is unknown.
In this cross-sectional survey involving 90 ischemic stroke patients, we studied endothelial function using ultrasonography, cerebral atherosclerosis and CMBs, aiming to investigate the relationships between them.
METHODS

Subjects
This was a cross-sectional study. Ninety patients hospitalized in Peking University First Hospital with acute ischemic stroke were enrolled consecutively between November 1, 2007 and January 31, 2008. Patients were eligible for inclusion if they had had an ischemic stroke within 1 week, their diagnosis was confirmed with neuroimaging, and they had a modified Rankin scale score of less than 4 at enrollment. Exclusion criteria included history of intracranial hemorrhage, serious complications such as heart or renal dysfunction or liver cirrhosis, peripheral vascular disease, ischemic stroke due to other definitive causes such as coagulation disorders, fever or acute inflammatory conditions, and MRI contraindications. On admission, we assessed the stroke severity by the National Institute of Health Stroke Scale (NIHSS). Stroke subtypes were determined by TOAST classification. 10 The clinical characteristics were recorded. Abnormal lipid profile was defined as the following: total cholesterol more than 5.2 mmol/L, low-density lipoprotein more than 3.12 mmol/L, triglyceride more than 1.70 mmol/L, and highdensity lipoprotein less than 0.91 mmol/L. Fasting blood glucose more than 7.0 mmol/L was regarded as abnormal glucose. Systolic/diastolic blood pressure (SBP/DBP) more than 140/90 mmHg (1 mmHg=0.133 kPa) and pulse pressure (PP) more than 60 mmHg, respectively, were considered high.
MRI studies
Brain MRI examinations were performed within 1 week from the onset on a 1.5 T magnetic resonance (MR) scanner (GE Medical System, USA) using a standard head coil. Sequences were obtained in the axial plane with the following parameters: slice thickness/interslice gap 6/1 mm, T1 (repetition time (TR)/echo time (TE)=1875/24 ms), T2 (TR/TE=4 500/102 ms), gradient recall echo (GRE) (TR/TE=545/20 ms), fluid attenuated inversion recovery (FLAIR) (TR/TE=8 400/120 ms), and diffusion weighted imaging (DWI) (TR/TE=5 000/60 ms). All the MRIs were copied to discs. Imaging analysis was reviewed independently by an investigator without knowledge of the clinical data. CMBs were defined as small, rounded, homogeneous foci of hypointensity or signal loss in brain parenchyma measuring 2-10 mm in size on GRE T2*WI. 11 Symmetric signal loss or hypointensity in the globus pallidus, likely to represent calcification, and signal loss in the cerebral arteries and veins must be disregarded in the diagnosis of CMBs.
Vascular examination
All subjects underwent transcranial Doppler and colorcoded duplex sonography of cervical arteries to detect the intima-media thickness (IMT), carotid plaques, and cerebral artery stenosis. IMT was measured according to the Mannheim IMT consensus. 12 IMT was measured on both sides 2 cm below the bifurcation and on the far wall of the common carotid artery. The distance between the characteristic echoes from the lumen-intima and media-adventitia interfaces was measured. Our final IMT value was based on the mean value of three maximal IMT measurements in three frames. Arterial stenosis was defined as a visible narrowing (>50% diameter) or significant hemodynamic changes according to ultrasonographic criteria. 13 While 11 cases had internal carotid artery stenosis, 25 cases had intracranial artery stenosis and 10 cases had both intracranial and extracranial artery stenosis. Among these 46 cases, 23 cases received magnetic resonance angiography, computed tomography angiography, or digital subtraction angiography and demonstrated the diagnosis. Patients with IMT≥1.0 mm, carotid plaque, and carotid artery stenosis were regarded as having carotid atherosclerosis, while patients with IMT<1.0 mm was defined as normal.
Endothelial function
All participants underwent examination of the brachial artery vasodilation according to the previously scheme described. 14, 15 A Siemens Sequoia (512) ultrasound system, equipped with an 8-14 MHz linear array transducer, was applied. The participants rested in supine position in a quiet room for 10 minutes before the first scan and then abducted their right arms for 15°. Two-dimensional images of the brachial artery were acquired in longitudinal section 5-10 cm above the elbow. Straight arterial wall segments were obtained at least 10 mm with both walls clearly visualized for optimal diameter measurements. Vertical dimension between the intima-lumen interfaces of both walls was measured as the diameter at images captured at end diastole in each cardiac cycle, which was determined by simultaneous monitoring of the electrocardiogram (concurrent with the onset of the QRS complex). The diameter was averaged over three cardiac cycles. A 10 cm cuff placed around the right upper arm was inflated to 50 mmHg above SBP for 5 minutes. The same brachial artery segment was interrogated 50-70 seconds after cuff deflation (period of reactive hyperemia). FMD was calculated as the percentage change in the diameter after reactive hyperemia, relative to the baseline.
After a 15-minute rest, endothelial-independent vascular function was assessed by measuring the same portion of the brachial artery 3 minutes after the administration of 0.5 mg sublingual nitroglycerin. Nitroglycerin-mediated dilation (NMD) was expressed as the percentage change in the diameter after nitroglycerin administration.
Statistical analysis
Statistical analysis was performed using the SPSS (version 13.0) (SPSS Inc. USA) software. χ 2 test was used to compare the frequency distribution of categorical variables between subgroups of individuals with and without CMBs. Continuous variables were compared with Student's t-test or Mann-Whitney test (nonnormally distributed). Multivariate Logistic regression model (backward elimination method, Wald) was used to find the independent risk factors for the presence of CMBs. A P <0.05 was considered statistically significant.
RESULTS
Clinical characteristics
There were 55 (61.1%) men and 35 (38.9%) women. Stroke subtypes were as follows: 58 large-artery atherothrombosis, 18 small-vessel occlusions, and 14 cardioembolisms. CMBs were present in 30 cases (33.3%). The median number was 2 (1, 30) . The frequency of CMBs in men (40%) was higher than in women (22.9%), but there was no significant difference (P=0.093). According to stroke subtypes, the frequency of CMBs was 32.8% (n=19) in large-artery atherothrombosis, 38.9% (n=7) in smallvessel occlusions, and 28.6% (n=4) in cardioembolisms. The clinical characteristics are summarized in Table 1 . Examples of CMBs are shown in Figure 1 . The mean SBP and DBP were higher in patients with CMBs than in those without (P <0.05). The median NIHSS was higher in CMBpositive patients than CMB-negative patients (4 and 1, respectively; P=0.01). History of previous ischemic stroke was more common in the CMB-positive group than the CMB-negative group (18 of 30 and 14 of 60, respectively; P=0.001).
CMBs presence and cerebral large-artery diseases
The frequencies of CMBs in patients with IMT≥1.0 mm, carotid plaque, and extracranial artery stenosis were 37.5%, 39.4% and 47.6% respectively, with no significant difference, but much higher than in patients with IMT<1.0 mm (5%, χ 2 =1.118, P=0.02, Table 2 ). However, there were no significant relationship between CMB presence and cerebral large-artery stenosis ( Table 3 , χ 2 =0.309, P=0.101). 
Endothelial function
Association factors for the presence of CMBs
According to the mean value of FMD (13%) and NMD (15%), FMD less than 13% and NMD less than 15% were regarded as impaired FMD and NMD, respectively. In the multivariate logistic regression for the presence of CMB, age, high SBP/DBP/PP, impaired FMD and NMD, carotid atherosclerosis, abnormal lipid profile, as well as other variables listed in Table 1 , were defined as independent Figure 1 . A gradient recall-echo T 2 * MRI shows two cerebral microbleeds in the left putamen and one cerebral microbleed in the right thalamus. variables. The results showed that impaired FMD was an independent risk factor for the presence of CMBs, as well as high PP and previous ischemic stroke (Table 4) .
DISCUSSION
Several studies found that arterial stiffness, evaluated by brachial-to-ankle pulse wave velocity, had an independent association with the presence of CMBs. 16, 17 In our study, we found that high PP was independently associated with the presence of CMBs. Similarly, a new index of systemic atherosclerosis, the cardio-ankle vascular index (CAVI) was reported significantly higher in CMBs than in non-CMB groups. A high CAVI was independently associated with CMBs in patients with acute ischemic stroke. 2 Our results showed that the frequency of CMB was much higher in patients with carotid atherosclerosis than those without (41.4% vs. 5.0%, P=0.002). However, the frequencies of CMBs were not significantly different in patients with different degrees of carotid atherosclerosis. And no significant relationships were demonstrated between CMBs and cerebral artery stenosis. In the logistic regression analysis, carotid atherosclerosis was associated with CMBs presence (P=0.071), but not independently. These results indicate that ischemic stroke patients with CMBs may have systemic atherosclerosis as well as arteriolosclerosis. CMBs may coexist with large-artery atherosclerosis because both small vessels and large arteries are exposed to the same vascular risk factors.
Vascular risk factors can affect both the endothelium and the vascular smooth muscle. When vascular smooth muscle is affected by risk factors, it also decreases the dilatory response to the endogenous and exogenous NO. Therefore, it is difficult to differentiate whether diminished FMD is caused by endothelial dysfunction, vascular smooth muscle dysfunction or both when a patient has low FMD. We evaluated the function of vascular smooth muscle using NMD. In our study, both FMD and NMD were lower in patients with CMBs compared to those without. However, in the multivariate analysis, only impaired FMD was associated with CMBs presence independently, while diminished NMD was not associated with CMBs presence. This suggested that impaired NMD might be affected by vascular risk factors, while diminished FMD was caused by not only vascular smooth muscle dysfunction but also endothelial dysfunction. As known, endothelial dysfunction is an early change of atherosclerosis and reflects functional alterations instead of morphologic changes. So we doubted that if the relationship between impaired FMD and CMBs presence was confused by atherosclerosis. It was reported that reduced FMD was significantly associated with increased maximal carotid plaque thickness. 18 Thus endothelial function may be more impaired in atherosclerotic occlusive cerebral arteries compared to non-stenotic arteries. In our study, FMD was slightly lower in CMB-positive patients with cerebral large-artery stenosis than those without, but it was not significant. This may suggest that endothelial dysfunction was not simply paralleled with atherosclerosis, but much severe than we expected. This was in accordance with other studies which demonstrated negative correlations between FMD and carotid IMT or revealed that a given level of atherosclerosis patients with small-vessel disease have additional endothelial impairment. 19, 20 Otherwise in the logistic regression analysis, impaired endothelial function was an independent predictor for CMBs presence while carotid atherosclerosis was not. This suggested that endothelial dysfunction may be involved in the pathogenesis of CMBs.
Pathologically, CMB was old blood extravasation and hemosiderin-containing macrophages aggregation after the destruction of the integrity of cerebral small vessel. Thus destruction of the vascular integrity was the underlying mechanism of CMB formation. As known, vascular endothelium has inflammatory effects potentially by secreting mediators of inflammation or regulating the adherence of leukocytes. Endothelial inflammatory response (the so-called endothelial activation) may play not only important roles in the initiation and progression of atherosclerosis, but also a crucial role in the process of cerebral small-vessel diseases. 4, 21 When endothelial dysfunction happens, local inflammation may lead to generation of free radical or release of mediators such as matrix metalloproteinase-9 which can destroy the matrix, increasing the vasopermeability and breakdown of the blood-brain barrier and basal membrane. 22 A recent study showed that high serum level of vascular endothelial growth factor is associated with the presence of CMBs in acute ischemic stroke. 23 Two other studies found that serum levels of adiponectin and sE-selectin were closely related to CMBs by adjusting other confounders. 3, 24 It was also reported that biomarkers of endothelial dysfunction were elevated in lacunar infarcts and leukoaraiosis. 8, 25, 26 Therefore, we speculated that vascular endothelial dysfunction may be the common underlying pathophysiologic mechanism of cerebral small-vessel diseases such as CMB, lacunar infarcts, and WML. However, further studies are needed to find out what finally causes these three kinds of smallvessel diseases with different features.
In conclusion, this study provides evidence of disordered endothelial function in patients with CMBs by demonstration of impaired FMD. Further studies with larger numbers of patients and combining measurements of plasma biomarkers of endothelial origin are needed to confirm our conclusion. If confirmed, then measures aimed at preserving vascular endothelial function such as application of angiotensin-converting enzyme inhibitor and statins may provide strategies for decreasing the CMBs load in the future.
